Lee Boram, Kwon Chan-Young, Jang Soobin
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Department of Oriental Neuropsychiatry, Dong-eui University College of Korean Medicine, Busan, South Korea.
Integr Med Res. 2022 Jun;11(2):100832. doi: 10.1016/j.imr.2022.100832. Epub 2022 Jan 5.
Idiopathic short stature (ISS) is a common problem in children and causes many economic and social burdens. In Asian countries, East Asian traditional medicine (EATM) therapies are widely used for children with ISS. In this study, we compared and ranked various EATM therapies for the treatment of pediatric ISS using network meta-analysis.
Randomized controlled trials that evaluated various EATMs for pediatric ISS were found through searching 14 electronic databases. The primary outcome was growth velocity (GV). The comparative effectiveness of the treatments was ranked based on the surface under the cumulative ranking curve (SUCRA) and the risk of bias was assessed. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluations approach.
Fourteen studies comprising 1,066 participants were included. HM plus GH showed statistically significant superiority over other EATM therapies including acupuncture (weighted mean difference (WMD) 3.20 cm, 95% confidence interval (CI) 0.40 to 5.99) and HM (WMD 3.70 cm, 95% CI 1.41 to 5.99) for improving GV per year, although there was no difference compared with GH alone (WMD 1.18 cm, 95% CI -0.27 to 2.63). SUCRA indicated that HM plus GH was the most effective therapy for increasing GV, followed by GH, HM plus acupressure, and HM. No serious adverse events were reported.
For the treatment of ISS, HM plus GH might have a large beneficial effect and might be a better option than EATM therapies and GH alone. However, more long-term, high-quality trials are warranted to confirm the findings.
PROSPERO (https://www.crd.york.ac.uk/prospero/), CRD42020187160.
特发性矮小(ISS)是儿童常见问题,会造成诸多经济和社会负担。在亚洲国家,东亚传统医学(EATM)疗法被广泛用于治疗患有ISS的儿童。在本研究中,我们使用网络荟萃分析比较并排序了治疗儿童ISS的各种EATM疗法。
通过检索14个电子数据库,找到了评估各种EATM疗法治疗儿童ISS的随机对照试验。主要结局指标是生长速度(GV)。基于累积排序曲线下面积(SUCRA)对治疗的比较效果进行排序,并评估偏倚风险。使用推荐分级、评估、制定与评价方法评估证据质量。
纳入了14项研究,共1066名参与者。中药加生长激素(GH)在改善每年的GV方面,相较于包括针灸(加权均数差(WMD)3.20 cm,95%置信区间(CI)0.40至5.99)和中药(WMD 3.70 cm,95%CI 1.41至5.99)在内的其他EATM疗法,显示出统计学上的显著优势,不过与单独使用GH相比无差异(WMD 1.18 cm,95%CI -0.27至2.63)。SUCRA表明,中药加GH是增加GV最有效的疗法,其次是GH、中药加指压按摩和中药。未报告严重不良事件。
对于ISS的治疗,中药加GH可能具有很大的有益效果,可能比单独的EATM疗法和GH是更好的选择。然而,需要更多长期、高质量的试验来证实这些发现。
国际前瞻性系统评价注册库(PROSPERO,https://www.crd.york.ac.uk/prospero/),CRD42020187160